GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

HSG4112

Company
Glaceum
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details
  • Completed NCT NCT04703764

    A Study to Investigate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of HSG4112

    Not yet reported Glaceum 40 participants Est. completion 2022-02-03 2 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT04732988

    A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics, and Food Effect of HSG4112

    Not yet reported Glaceum 90 participants Est. completion 2021-05-24 2 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT04733001

    A Study to Investigate the Effect of Food on the Pharmacokinetics of HSG4112

    Not yet reported Glaceum 12 participants Est. completion 2021-02-10 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT05197556

    A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients

    Not yet reported Glaceum 81 participants Est. completion 2023-04-04 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT05310032

    A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HSG4112 in High Doses

    Not yet reported Glaceum 36 participants Est. completion 2023-03-31 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06329141

    A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

    Not yet reported Glaceum 99 participants Est. completion 2026-01-07 9 sites
    Other conditions: Parkinson Disease
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.